Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

Share Price is delayed by 15 minutes
Get Live Data
295.80    10.40 (3.64%)
Bid:
296.80
Ask:
297.40
Spread: 0.60 (0.202%)
Market Cap: £1.03b
BREE Live PriceLast checked at - London Stock Exchange

Intraday Breedon Share Chart

Trading Statement

26 Nov 2012 07:00

RNS Number : 9338R
Breedon Aggregates Ld
26 November 2012
 



 

 

 

News release

 

26 November 2012

BREEDON AGGREGATES LIMITED

("Breedon" or the "Group")

Trading Update

Breedon Aggregates Limited issues the following statement in advance of its preliminary results announcement due on 5 March 2013.

Trading Performance

Anticipated trading results for the year to 31 December 2012 remain in line with market expectations, assuming normal weather conditions in December. Sales volumes of aggregates and ready-mixed concrete are ahead in both England and Scotland, assisted by positive contributions from acquisitions, C&G Concrete and Nottingham Readymix in England and Rothes Glen in Scotland. Sales volumes of asphalt are down year on year in line with market demand.

Sales revenue in the second half of the year has been slightly stronger than the first half and the EBITDA margin improvements reported in the first half have been largely maintained.

Operational progress

Breedon continues to make good progress, despite the significant difficulties faced by the UK construction market, with reported construction output and mineral production volumes both sharply down in the year to date. We have maintained our focus on management of costs and careful selection of work, with the result that both England and Scotland have made solid progress this year.

In October we announced our withdrawal from bidding for the majority of the Lafarge and Tarmac assets being divested as a precondition of their construction materials joint venture. We were ultimately unable to match the value expectations of the sellers for any of the assets on offer, in line with our often-stated position that we will only pursue acquisitions which add value for our shareholders. Several other potential acquisition opportunities are currently being investigated.

Outlook

The outlook for 2013 remains uncertain, with the Construction Products Association forecasting no return to growth before 2014. However, our management team have repeatedly demonstrated their ability to deliver superior performance in difficult markets and we remain confident that we will make further progress next year.

More about Breedon Aggregates

Breedon Aggregates Limited is the largest independent aggregates group in the UK after the five global majors. It operates 27 quarries, 18 asphalt plants and 40 ready-mixed concrete plants in England and Scotland and employs approximately 800 people.

The group has strong asset backing, with nearly 200 million tonnes of mineral reserves and resources in the UK.

Breedon Aggregates' strategy is to grow through consolidation of the UK heavyside building materials sector.

For further information:

Breedon Aggregates Limited

Peter Tom, Chairman

Simon Vivian, Group Chief Executive

Ian Peters, Group Finance Director

01332 694010

 

Stephen Jacobs, Head of Communications

07831 764592

 

Cenkos Securities plc

Max Hartley / Nicholas Wells

020 7397 8900

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTQXLFLLFFXFBB
Date   Source Headline
1st Jun 202310:37 amRNSHolding(s) in Company
31st May 202312:35 pmRNSTotal Voting Rights
31st May 202311:30 amRNSHolding(s) in Company
24th May 202312:35 pmRNSDirector/PDMR Shareholding
23rd May 20235:31 pmRNSHolding(s) in Company
22nd May 202311:24 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
18th May 20234:52 pmRNSDirector/PDMR Shareholding
18th May 20239:00 amRNSBreedon plays key role in Peak Cluster initiative
18th May 20238:00 amRNSAcquisitions
17th May 20238:00 amRNSReadmission - Breedon Group plc
17th May 20237:00 amRNSAdmission to Main Market
12th May 20236:00 pmRNSBreedon Group
12th May 20233:50 pmRNSDirector/PDMR Shareholding
11th May 202312:56 pmRNSPublication of Prospectus
4th May 202310:06 amRNSHolding(s) in Company
28th Apr 20237:00 amRNSHolding(s) in Company
26th Apr 20234:41 pmRNSResult of Scheme Meetings & Annual General Meeting
26th Apr 20237:00 amRNSAGM Trading Update
24th Apr 20232:22 pmRNSHolding(s) in Company
13th Apr 20236:08 pmRNSHolding(s) in Company
13th Apr 202312:12 pmRNSHolding(s) in Company
12th Apr 20234:50 pmRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSPublication of Scheme Document
24th Mar 20233:49 pmRNSHolding(s) in Company
20th Mar 20239:00 amRNS2022 Annual Report and Notice of AGM
10th Mar 20235:34 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSResults of Reverse Accelerated Bookbuild
9th Mar 20234:56 pmRNSStatement re Reverse Accelerated Bookbuild
9th Mar 20231:36 pmRNSDirector/PDMR Shareholding
8th Mar 20237:00 amRNSIntention to move from AIM to the Main Market
8th Mar 20237:00 amRNSFinal Results
8th Feb 20238:00 amRNSNotice of Results
6th Feb 20231:29 pmRNSDirector/PDMR Shareholding
6th Jan 202310:08 amRNSBlocklisting Update
23rd Dec 202210:00 amRNSTotal Voting Rights
19th Dec 202212:57 pmRNSHolding(s) in Company
2nd Dec 20224:01 pmRNSHolding(s) in Company
30th Nov 20229:28 amRNSTotal Voting Rights
25th Nov 20227:00 amRNSNovember trading statement
27th Oct 20224:23 pmRNSStandard form for notification of major holdings
26th Oct 20229:18 amRNSNotice of trading update
3rd Oct 20223:27 pmRNSPDMR Dealings
30th Sep 20224:20 pmRNSDirector Dealings
23rd Sep 20225:09 pmRNSStandard form for notification of major holdings
6th Sep 20225:19 pmRNSStandard form for notification of major holdings
25th Aug 20224:13 pmRNSDirector/PDMR Shareholding
27th Jul 20227:00 amRNSInterim results 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.